Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions

Mutagenesis

Volumn 27, Issue 3, 2012, Pages 337-343

  Dzikiewicz Krawczyk, Agnieszka ^a   Mosor, Maria ^a   Januszkiewicz, Danuta ^b   Nowak, Jerzy ^a  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H2AX; HISTONE H2AX GAMMA; NBN PROTEIN; NIBRIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE S PHASE; CELL MUTANT; CHROMATID ABERRATION; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIOSENSITIVITY;

CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CELL SURVIVAL; CELLS, CULTURED; DNA; DNA BREAKS, DOUBLE-STRANDED; DNA REPEAT EXPANSION; HETEROZYGOTE; HISTONES; HUMANS; MUTATION, MISSENSE; NIJMEGEN BREAKAGE SYNDROME; NUCLEAR PROTEINS; RADIATION TOLERANCE; RADIATION, IONIZING; S PHASE CELL CYCLE CHECKPOINTS; SEQUENCE DELETION;

EID: 84860204988     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger084     Document Type: Article

References (74)

1. Petrini, J. H. J. and Stracker, T. H. (2003) The cellular response to DNA double-strand breaks: defining the sensors and mediators. Trends Cell Biol., 13, 458-462.
2. Kobayashi, J., Antoccia, A., Tauchi, H., Matsuura, S. and Komatsu, K. (2004) NBS1 and its functional role in the DNA damage response. DNA Repair (Amst.), 3, 855-861.
3. Riches, L. C., Lynch, A. M. and Gooderham, N. J. (2008) Early events in the mammalian response to DNA double-strand breaks. Mutagenesis, 23, 331-339.
4. Falck, J., Petrini, J. H., Williams, B. R., Lukas, J. and Bartek, J. (2002) The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat. Genet., 30, 290-294.
5. Carson, C. T., Schwartz, R. A., Stracker, T. H., Lilley, C. E., Lee, D. V. and Weitzman, M. D. (2003) The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J., 22, 6610-6620.
6. Marcelain, K., de la Torre, C., González, P. and Pincheira, J. (2005) Roles of nibrin and ATM/ATR kinases on the G2 checkpoint under endogenous or radio-induced DNA damage. Biol. Res., 38, 179-185.
7. Difilippantonio, S., Celeste, A., Kruhlak, M., Lee, Y., Difilippantonio, M. J., Feigenbaum, L., Jackson, S. P., McKinnon, P. J. and Nussenzweig, A. (2007) Distinct domains in Nbs1 regulate irradiation-induced checkpoints and apoptosis. J. Exp. Med., 204, 1003-1011.
8. Olson, E., Nievera, C. J., Liu, E., Lee, A. Y., Chen, L. and Wu, X. (2007) The Mre11 complex mediates the S-phase checkpoint through an interaction with replication protein A. Mol. Cell. Biol., 27, 6053-6067.
9. Morales, M., Theunissen, J. W., Kim, C. F., Kitagawa, R., Kastan, M. B. and Petrini, J. H. (2005) The Rad50S allele promotes ATM-dependent DNA damage responses and suppresses ATM deficiency: implications for the Mre11 complex as a DNA damage sensor. Genes Dev., 19, 3043-3054.
10. Stracker, T. H., Morales, M., Couto, S. S., Hussein, H. and Petrini, J. H. (2007) The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex. Nature, 447, 218-221.
11. Costanzo, V., Robertson, K., Bibikova, M., Kim, E., Grieco, D., Gottesman, M., Carroll, D. and Gautier, J. (2001) Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication. Mol. Cell, 8, 137-147.
12. Maser, R. S., Mirzoeva, O. K., Wells, J., Olivares, H., Williams, B. R., Zinkel, R. A., Farnham, P. J. and Petrini, J. H. (2001) Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol. Cell. Biol., 21, 6006-6016.
13. Shimada, M., Sagae, R., Kobayashi, J., Habu, T. and Komatsu, K. (2009) Inactivation of the Nijmegen breakage syndrome gene leads to excess centrosome duplication via the ATR/BRCA1 pathway. Cancer Res., 69, 1768-1775.
14. Borde, V. (2007) The multiple roles of the Mre11 complex for meiotic recombination. Chromosome Res., 15, 551-563.
15. Chai, W., Sfeir, A. J., Hoshiyama, H., Shay, J. W. and Wright, W. E. (2006) The involvement of the Mre11/Rad50/Nbs1 complex in the generation of G-overhangs at human telomeres. EMBO Rep., 7, 225-230.
16. Slijepcevic, P. (2006) The role of DNA damage response proteins at telomeres-an "integrative" model. DNA Repair (Amst.), 5, 1299-1306.
17. Lähdesmäki, A., Taylor, A. M., Chrzanowska, K. H. and Pan- Hammarström, Q. (2004) Delineation of the role of the Mre11 complex in class switch recombination. J. Biol. Chem., 279, 16479-16487.
18. Reina-San-Martin, B., Nussenzweig, M. C., Nussenzweig, A. and Difilippantonio, S. (2005) Genomic instability, endoreduplication and diminished Ig class-switch recombination in B cells lacking Nbs1. Proc. Natl. Acad. Sci. U S A, 102, 1590-1595.
19. Xu, C., Wu, L., Cui, G., Botuyan, M. V., Chen, J. and Mer, G. (2008) Structure of a second BRCT domain identified in the Nijmegen breakage syndrome protein Nbs1 and its function in an MDC1-dependent localization of Nbs1 to DNA damage sites. J. Mol. Biol., 381, 361-372.
20. Lloyd, J., Chapman, J. R., Clapperton, J. A., Haire, L. F., Hartsuiker, E., Li, J., Carr, A. M., Jackson, S. P. and Smerdon, S. J. (2009) A supramodular FHA/BRCT-repeat architecture mediates Nbs1 adaptor function in response to DNA damage. Cell, 139, 100-111.
21. Hari, F. J., Spycher, C., Jungmichel, S., Pavic, L. and Stucki, M. (2010) A divalent FHA/BRCT-binding mechanism couples the MRE11-RAD50- NBS1 complex to damaged chromatin. EMBO Rep., 11, 387-392.
22. Zhu, J., Petersen, S., Tessarollo, L. and Nussenzweig, A. (2001) Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr. Biol., 11, 105-109.
23. Digweed, M. and Sperling, K. (2004) Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst.), 3, 1207-1217.
24. Sullivan, K. E., Veksler, E., Lederman, H. and Lees-Miller, S. P. (1997) Cell cycle checkpoints and DNA repair in Nijmegen breakage syndrome. Clin. Immunol. Immunopathol., 82, 43-48.
25. Kraakman-van der Zwet, M., Overkamp, W. J., Friedl, A. A. et al. (1999) Immortalization and characterization of Nijmegen breakage syndrome fibroblasts. Mutat. Res., 434, 17-27.
26. Pluth, J. M., Yamazaki, V., Cooper, B. A., Rydberg, B. E., Kirchgessner, C. U. and Cooper, P. K. (2008) DNA double-strand break and chromosomal rejoining defects with misrejoining in Nijmegen breakage syndrome cells. DNA Repair (Amst.), 7, 108-118.
27. Maser, R. S., Zinkel, R. and Petrini, J. H. (2001) An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele. Nat. Genet., 27, 417-421.
28. Seemanová, E., Sperling, K., Neitzel, H., Varon, R., Hadac, J., Butova, O., Schröck, E., Seeman, P. and Digweed, M. (2006) Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability. J. Med. Genet., 43, 218-224.
29. Seemanová, E. (1990) An increased risk for malignant neoplasms in heterozygotes for a syndrome of microcephaly, normal intelligence, growth retardation, remarkable facies, immunodeficiency and chromosomal instability. Mutat. Res., 238, 321-324.
30. Dzikiewicz-Krawczyk, A. (2008) The importance of making ends meet: mutations in genes and altered expression of proteins of the MRN complex and cancer. Mutat. Res., 659, 262-273.
31. di Masi, A., Viganotti, M., Polticelli, F., Ascenzi, P., Tanzarella, C. and Antoccia, A. (2008) The R215W mutation in NBS1 impairs gamma-H2AX binding and affects DNA repair: molecular bases for the severe phenotype of 657del5/R215W Nijmegen breakage syndrome patients. Biochem. Biophys. Res. Commun., 369, 835-840.
32. Shimada, H., Shimizu, K., Mimaki, S. et al. (2004) First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability. Hum. Genet., 115, 372-376.
33. Mosor, M., Ziółkowska, I., Pernak-Schwarz, M., Januszkiewicz- Lewandowska, D. and Nowak, J. (2006) Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia. Leukemia, 20, 1454-1456.
34. Rożnowski, K., Januszkiewicz-Lewandowska, D., Mosor, M., Pernak, M., Litwiniuk, M. and Nowak, J. (2007) I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer. Breast Cancer Res. Treat., 110, 343-348.
35. Bryant, P. E., Gray, L., Riches, A. C. et al. (2002) The G2 chromosomal radiosensitivity assay. Int. J. Radiat. Biol., 78, 863-866.
36. Krüger, L., Demuth, I., Neitzel, H., Varon, R., Sperling, K., Chrzanowska, K. H., Seemanova, E. and Digweed, M. (2007) Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein. Carcinogenesis, 28, 107-111.
37. Lins, S., Kim, R., Krüger, L., Chrzanowska, K. H., Seemanova, E. and Digweed, M. (2009) Clinical variability and expression of the NBN c.657del5 allele in Nijmegen breakage syndrome. Gene, 447, 12-17.
38. Tanzarella, C., Antoccia, A., Spadoni, E. et al. (2003) Chromosome instability and nibrin protein variants in NBS heterozygotes. Eur. J. Hum. Genet., 11, 297-303.
39. Stumm, M., Neubauer, S., Keindorff, S., Wegner, R. D., Wieacker, P. and Sauer, R. (2001) High frequency of spontaneous translocations revealed by FISH in cells from patients with the cancer-prone syndromes ataxia telangiectasia and Nijmegen breakage syndrome. Cytogenet. Cell Genet., 92, 186-191.
40. Neubauer, S., Arutyunyan, R., Stumm, M., Dörk, T., Bendix, R., Bremer, M., Varon, R., Sauer, R. and Gebhart, E. (2002) Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three-color FISH chromosome painting. Radiat. Res., 157, 312-321.
41. Distel, L. V., Neubauer, S., Keller, U., Sprung, C. N., Sauer, R. and Grabenbauer, G. G. (2006) Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients. Radiother. Oncol., 81, 257-263.
42. Bürger, S., Schindler, D., Fehn, M., Mühl, B., Mahrhofer, H., Flentje, M., Hoehn, H., Seemanová, E. and Djuzenova, C. S. (2006) Radiation-induced DNA damage and repair in peripheral blood mononuclear cells from Nijmegen breakage syndrome patients and carriers assessed by the Comet assay. Environ. Mol. Mutagen., 47, 260-270.
43. Girard, P. M., Foray, N., Stumm, M. et al. (2000) Radiosensitivity in Nijmegen breakage syndrome cells is attributable to a repair defect and not cell cycle checkpoint defects. Cancer Res., 60, 4881-4888.
44. Wojewódzka, M., Buraczewska, I. and Kruszewski, M. (2002) A modified neutral comet assay: elimination of lysis at high temperature and validation of the assay with anti-single-stranded DNA antibody. Mutat. Res., 518, 9-20.
45. Sagan, D., Müller, R., Kröger, C., Hematulin, A., Mö rtl, S. and Eckardt- Schupp, F. (2009) The DNA repair protein NBS1 influences the base excision repair pathway. Carcinogenesis, 30, 408-415.
46. Belyaev, I. Y. (2010) Radiation-induced DNA repair foci: spatio-temporal aspects of formation, application for assessment of radiosensitivity and biological dosimetry. Mutat. Res., 704, 132-141.
47. Williams, R. S., Dodson, G. E., Limbo, O. et al. (2009) Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA double-strand break processing and repair. Cell, 139, 87-99.
48. Bogdanova, N., Feshchenko, S., Schürmann, P. et al. (2008) Nijmegen breakage syndrome mutations and risk of breast cancer. Int. J. Cancer, 122, 802-806.
49. Resnick, I. B., Kondratenko, I., Pashanov, E. et al. (2003) 657del5 mutation in the gene for Nijmegen breakage syndrome NBS1. in a cohort of Russian children with lymphoid tissue malignancies and controls. Am. J. Med. Genet. A., 120, 174-179.
50. Chrzanowska, K. H., Piekutowska-Abramczuk, D., Popowska, E. et al. (2006) Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies. Int. J. Cancer, 118, 1269-1274.
51. Steffen, J., Maneva, G., Popławska, L., Varon, R., Mioduszewska, O. and Sperling, K. (2006) Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation. Int. J. Cancer, 119, 2970-2973.
52. Górski, B., Dȩbniak, T., Masojć, B. et al. (2003) Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int. J. Cancer, 106, 379-381.
53. Buslov, K. G., Iyevleva, A. G., Chekmariova, E. V. et al. (2005) NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. Int. J. Cancer, 114, 585-589.
54. Steffen, J., Nowakowska, D., Niwińska, A., Czapczak, D., Kluska, A., Pia̧tkowska, M., Wisńiewska, A. and Paszko, Z. (2006) Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int. J. Cancer, 119, 472-475.
55. Cybulski, C., Górski, B., Dȩbniak, T. et al. (2004) NBS1 is a prostate cancer susceptibility gene. Cancer Res., 64, 1215-1219.
56. Stanulla, M., Stümm, M., Dieckvoss, B. O., Seidemann, K., Schemmel, V., Brechlin, A. M., Schrappe, M., Welte, K. and Reiter, A. (2000) No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence. Br. J. Haematol., 109, 117-120.
57. Rischewski, J., von Bismarck, P., Kabisch, H., Janka-Schaub, G., Obser, T. and Schneppenheim, R. (2000) The common deletion 657del5 in the nibrin gene is not a major risk factor for B or T cell non-Hodgkin lymphoma in a pediatric population. Leukemia, 14, 1528-1529.
58. Cerosaletti, K. M., Morrison, V. A., Sabath, D. E., Willerford, D. M. and Concannon, P. (2002) Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma. Genes Chromosomes Cancer, 35, 282-286.
59. Taylor, G. M., O'Brien, H. P., Greaves, M. V., Ravetto, P. F. and Eden, O. B. (2003) Correspondence re: R. Varon et al., Mutations in the Nijmegen breakage syndrome gene (NBS1). in childhood acute lymphoblastic leukemia. Cancer Res., 61: 3570-3572
60. 2001. Cancer Res., 63, 6563-6564.
61. Steffen, J., Varon, R., Mosor, M. et al. (2004) Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int. J. Cancer, 11, 67-71.
62. Gó rski, B., Cybulski, C., Huzarski, T. et al. (2005) Breast cancer predisposing alleles in Poland. Breast Cancer Res. Treat., 92, 19-24.
63. Kanka, C., Brożek, I., Skalska, B., Siemia̧tkowska, A. and Limon, J. (2007) Germline NBS1 mutations in families with aggregation of breast and/or ovarian cancer from north-east Poland. Anticancer Res., 27, 3015-3018.
64. Varon, R., Reis, A., Henze, G., von Einsiedel, H. G., Sperling, K. and Seeger, K. (2001) Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL). Cancer Res., 61, 3570-3572.
65. Ziółkowska, I., Mosor, M., Wierzbicka, M., Rydzanicz, M., Pernak-Schwarz, M. and Nowak, J. (2007) Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Cancer Sci., 98, 1701-1705.
66. Nowak, J., Mosor, M., Ziółkowska, I. et al. (2008) Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours. Eur. J. Cancer, 44, 627-630.
67. Bogdanova, N., Schürmann, P., Waltes, R., Feshchenko, S., Zalutsky, I. V., Bremer, M. and Dö rk, T. (2008) NBS1 variant I171V and breast cancer risk. Breast Cancer Res. Treat., 112, 75-79.
68. Nowak, J., Mosor, M., Nowicka, K., Rembowska, J. and Januszkiewicz, D. (2011) Is the NBN gene mutation I171V a potential risk factor for malignant solid tumors in Children? J. Pediatr. Hematol. Oncol., 33, e248-e249.
69. Piekutowska-Abramczuk, D., Ciara, E., Popowska, E. et al. (2010) The frequency of NBN molecular variants in pediatric astrocytic tumors. J. Neurooncol., 96, 161-168.
70. Hebbring, S. J., Fredriksson, H., White, K. A. et al. (2006) Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer. Cancer Epidemiol. Biomarkers Prev., 15, 935-938.
71. Bartek, J., Lukas, J. and Bartkova, J. (2007) DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'. Cell Cycle, 6, 2344-2347.
72. Demuth, I. and Digweed, M. (2007) The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome. Oncogene, 26, 7792-7798.
73. Santarosa, M. and Ashworth, A. (2004) Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochim. Biophys. Acta, 1654, 105-122.
74. Smilenov, L. B. (2006) Tumor development: haploinsufficiency and local network assembly. Cancer Lett., 240, 17-28.